Clinical Trial Update: First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1 [Phase 1]

View source ↗

Summary

This trial update reports the first-in-human study of ALS-002200, including single-dose and food-effect evaluation in healthy volunteers and multiple-dose asses…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ALS-002200

Snippet

Sponsor: Alios Biopharma Inc. | Conditions: Hepatitis C, Chronic | Phase 1 | Status: COMPLETED